| Year |
Citation |
Score |
| 2017 |
Sims JR, Selzler KJ, Downing AM, Willis BA, Aluise CD, Zimmer J, Bragg S, Andersen S, Ayan-Oshodi M, Liffick E, Eads J, Wessels AM, Monk S, Schumi J, Mullen J. Development Review of the BACE1 Inhibitor Lanabecestat (AZD3293/LY3314814). The Journal of Prevention of Alzheimer's Disease. 4: 247-254. PMID 29181490 DOI: 10.14283/jpad.2017.38 |
0.365 |
|
| 2015 |
Aluise CD, Camarillo JM, Shimozu Y, Galligan JJ, Rose KL, Tallman KA, Marnett LJ. Site-specific, intramolecular cross-linking of Pin1 active site residues by the lipid electrophile 4-oxo-2-nonenal. Chemical Research in Toxicology. 28: 817-27. PMID 25739016 DOI: 10.1021/Acs.Chemrestox.5B00038 |
0.309 |
|
| 2013 |
Aluise CD, Rose K, Boiani M, Reyzer ML, Manna JD, Tallman K, Porter NA, Marnett LJ. Peptidyl-prolyl cis/trans-isomerase A1 (Pin1) is a target for modification by lipid electrophiles. Chemical Research in Toxicology. 26: 270-9. PMID 23231502 DOI: 10.1021/Tx300449G |
0.374 |
|
| 2013 |
Galligan JJ, Rose KL, Beavers WN, Aluise CD, Shuck SC, Marnett LJ. Abstract A12: Alkylation of histones by 4-oxo-2-nonenal as a novel modification linked to oxidative stress Cancer Research. 73. DOI: 10.1158/1538-7445.Cec13-A12 |
0.36 |
|
| 2013 |
Aluise CD, Marnett LJ. Pin1 is a Target for Oxidative Modification by the Lipid Electrophiles 4-Hydroxynonenal and 4- Oxononenal Free Radical Biology and Medicine. 65: S139. DOI: 10.1016/J.Freeradbiomed.2013.10.743 |
0.374 |
|
| 2011 |
Aluise CD, Miriyala S, Noel T, Sultana R, Jungsuwadee P, Taylor TJ, Cai J, Pierce WM, Vore M, Moscow JA, St Clair DK, Butterfield DA. 2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-α release: implications for the reactive oxygen species-mediated mechanisms of chemobrain. Free Radical Biology & Medicine. 50: 1630-8. PMID 21421044 DOI: 10.1016/J.Freeradbiomed.2011.03.009 |
0.546 |
|
| 2011 |
Aluise CD, Robinson RA, Cai J, Pierce WM, Markesbery WR, Butterfield DA. Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer's disease: insights into memory loss in MCI. Journal of Alzheimer's Disease : Jad. 23: 257-69. PMID 20930294 DOI: 10.3233/Jad-2010-101083 |
0.578 |
|
| 2010 |
Owen JB, Sultana R, Aluise CD, Erickson MA, Price TO, Bu G, Banks WA, Butterfield DA. Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for Aβ accumulation in AD brain. Free Radical Biology & Medicine. 49: 1798-803. PMID 20869432 DOI: 10.1016/J.Freeradbiomed.2010.09.013 |
0.623 |
|
| 2010 |
Aluise CD, Sultana R, Tangpong J, Vore M, St Clair D, Moscow JA, Butterfield DA. Chemo brain (chemo fog) as a potential side effect of doxorubicin administration: role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction. Advances in Experimental Medicine and Biology. 678: 147-56. PMID 20738017 DOI: 10.1007/978-1-4419-6306-2_19 |
0.499 |
|
| 2010 |
Huang Q, Aluise CD, Joshi G, Sultana R, St Clair DK, Markesbery WR, Butterfield DA. Potential in vivo amelioration by N-acetyl-L-cysteine of oxidative stress in brain in human double mutant APP/PS-1 knock-in mice: toward therapeutic modulation of mild cognitive impairment. Journal of Neuroscience Research. 88: 2618-29. PMID 20648652 DOI: 10.1002/Jnr.22422 |
0.627 |
|
| 2010 |
Aluise CD, Robinson RA, Beckett TL, Murphy MP, Cai J, Pierce WM, Markesbery WR, Butterfield DA. Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics. Neurobiology of Disease. 39: 221-8. PMID 20399861 DOI: 10.1016/J.Nbd.2010.04.011 |
0.595 |
|
| 2010 |
Joshi G, Aluise CD, Cole MP, Sultana R, Pierce WM, Vore M, St Clair DK, Butterfield DA. Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: implications for oxidative stress-mediated chemobrain. Neuroscience. 166: 796-807. PMID 20096337 DOI: 10.1016/J.Neuroscience.2010.01.021 |
0.583 |
|
| 2009 |
Aluise CD, St Clair D, Vore M, Butterfield DA. In vivo amelioration of adriamycin induced oxidative stress in plasma by gamma-glutamylcysteine ethyl ester (GCEE). Cancer Letters. 282: 25-9. PMID 19342159 DOI: 10.1016/J.Canlet.2009.02.047 |
0.567 |
|
| 2008 |
Aluise CD, Sowell RA, Butterfield DA. Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease. Biochimica Et Biophysica Acta. 1782: 549-58. PMID 18760351 DOI: 10.1016/J.Bbadis.2008.07.008 |
0.531 |
|
| 2008 |
Aluise CD. P1-353: Toward biomarker developments in Alzheimer's disease: Proteomic analysis of blood plasma from normally cognitive persons compared with plasma from the same persons following diagnosis of Alzheimer's disease Alzheimer's & Dementia. 4: T322-T322. DOI: 10.1016/J.Jalz.2008.05.935 |
0.355 |
|
| Show low-probability matches. |